전신성 홍반성 루푸스 환자에서 Intravenous Vancomycin 투여로 인한 루푸스 활성기 증례 보고
Vancomycin Induced Lupus Flare in a Patient with Systemic Lupus Erythematosus: A Clinical Case Report
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We report an unusual case of lupus flare induced by intravenous vancomycin in a patient with systemic lupus erythematosus. Due to methicillin resistant staphylococcus aureus in wound culture, intravenous vancomycin was administered to the patient. The patient had been on vancomycin for several days then she experienced fever, malar rash, and vomiting. Based on laboratory results, it was confirmed as lupus flare. Oral prednisolone was given to the patient for symptom control. However, when vancomycin was readministered, the patient had similar symptom to the previous one more intensively. Vancomycin was stopped then the patient became stable. This case report demonstrates that intravenous vancomycin may manifest as lupus flare in patients with systemic lupus erythematosus.
Abstract
We report an unusual case of lupus flare induced by intravenous vancomycin in a patient with systemic lupus erythematosus. Due to methicillin resistant staphylococcus aureus in wound culture, intravenous vancomycin was administered to the patient. The patient had been on vancomycin for several days then she experienced fever, malar rash, and vomiting. Based on laboratory results, it was confirmed as lupus flare. Oral prednisolone was given to the patient for symptom control. However, when vancomycin was readministered, the patient had similar symptom to the previous one more intensively. Vancomycin was stopped then the patient became stable. This case report demonstrates that intravenous vancomycin may manifest as lupus flare in patients with systemic lupus erythematosus.
참고문헌 (11)
- American Society of Health-System Pharmacists, "Vancomycin hydrochloride, In: American Society of Health-System Pharmacists" (2010), AHFS Drug Information
- American Pharmacists Association, "Vancomycin, In American Pharmacists Association. Drug Information Handbook: Lexi-Comp®", pp.1614~1617 (2008)
- MoelleringRC, "Pharmacokinetics of vancomycin", J Antimicrob Chemother, 14, pp.S43~S52 (1984)
- Krogstad DJ, "Single-dose kinetics of intravenous vancomycin", J Clin Pharmacol, 20, pp.197~201 (1980)
- Rybak MJ, "Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists", Clin Infect Dis, 49, pp.325~327 (2009)
- Rotschafer JC, "Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations", Antimicrob Agents Chemother, 22, pp.391~394 (1982)
- Sivagnanam S, "Red man syndrome", Crit Care, 7, pp.119~120 (2003)
- Ngeow WC, "Red man syndrome during administration of prophylactic antibiotic against infective endocarditis", J Ir Dent Assoc, 46, pp.92~94 (2000)
- Naranjo CA, "A method for estimating the probability of adverse drug reactions", Clin Pharmacol Ther, 30, pp.239~245 (1981)
- Gill JM, "Diagnosis of systemic lupus erythematosus", Am Fam Physician, 68, pp.2179~2186 (2003)
- Manocha D, "Vancomycin leading to lupus flare in an elderly lady: a case report", Cases J, 2, pp.6293~ (2009)